Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Anne M. Hause"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Introduction COVID-19 vaccines may be administered with other vaccines during the same healthcare visit. COVID-19 monovalent (Fall 2021) and bivalent (Fall 2022) vaccine recommendations coincided with annual seasonal influenza vaccination. Data descr
Externí odkaz:
https://doaj.org/article/eec475062d8349339ac3d89d097f006d
Autor:
Tanya R. Myers, Paige L. Marquez, Julianne M. Gee, Anne M. Hause, Lakshmi Panagiotakopoulos, Bicheng Zhang, Isaac McCullum, Charles Licata, Christine K. Olson, Shakeeb Rahman, Sharon B. Kennedy, Matthew Cardozo, Chirayu R. Patel, Liza Maxwell, Joel R. Kallman, David K. Shay, Tom T. Shimabukuro
Publikováno v:
Vaccine. 41:1310-1318
Autor:
Anne M. Hause, Paige Marquez, Bicheng Zhang, John R. Su, Tanya R. Myers, Julianne Gee, Sarada S. Panchanathan, Deborah Thompson, Tom T. Shimabukuro, David K. Shay
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 72:39-43
Autor:
Anne M, Hause, Paige, Marquez, Bicheng, Zhang, Tanya R, Myers, Julianne, Gee, John R, Su, Casey, Parker, Deborah, Thompson, Sarada S, Panchanathan, Tom T, Shimabukuro, David K, Shay
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:1115-1120
Autor:
Anne M, Hause, James, Baggs, Paige, Marquez, Tanya R, Myers, John R, Su, Brandon, Hugueley, Deborah, Thompson, Julianne, Gee, Tom T, Shimabukuro, David K, Shay
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:1047-1051
On May 17, 2022, the Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine to authorize a homologous* booster dose for children aged 5-11 years ≥5 months after receipt of th
Autor:
Tat'Yana A. Kenigsberg, Anne M. Hause, Michael M. McNeil, Jennifer C. Nelson, Jo Ann Shoup, Kristin Goddard, Yingbo Lou, Kayla E. Hanson, Sungching C. Glenn, Eric S. Weintraub
Publikováno v:
Vaccine. 40:3064-3071
The Vaccine Safety Datalink (VSD) conducts active surveillance and vaccine safety research studies. Since the start of the U.S. COVID-19 vaccination program, the VSD has conducted near real-time safety surveillance of COVID-19 vaccines using Rapid Cy
Autor:
Anne M. Hause, James Baggs, Paige Marquez, Winston E. Abara, Babatunde Olubajo, Tanya R. Myers, John R. Su, Deborah Thompson, Julianne Gee, Tom T. Shimabukuro, David K. Shay
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:347-351
Autor:
Anne M, Hause, James, Baggs, Paige, Marquez, Tanya R, Myers, John R, Su, Phillip G, Blanc, Jane A, Gwira Baumblatt, Emily Jane, Woo, Julianne, Gee, Tom T, Shimabukuro, David K, Shay
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:249-254
During September 22, 2021-February 6, 2022, approximately 82.6 million U.S. residents aged ≥18 years received a COVID-19 vaccine booster dose.* The Food and Drug Administration (FDA) has authorized a booster dose of either the same product administ
Autor:
Anne M. Hause, Paige Marquez, Bicheng Zhang, Tanya R. Myers, Julianne Gee, John R. Su, Phillip G. Blanc, Alisha Thomas, Deborah Thompson, Tom T. Shimabukuro, David K. Shay
Publikováno v:
MMWR. Morbidity and mortality weekly report. 71(44)
On August 31, 2022, the Food and Drug Administration (FDA) authorized bivalent formulations of BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) COVID-19 vaccines; these vaccines include mRNA encoding the spike protein from the original (ancestral)
Autor:
Erin F. Blau, Andrea Flinchum, Kathryn L. Gaub, Kathleen P. Hartnett, Michael Curran, Virginia K. Allen, Allison Napier, Elisabeth M. Hesse, Anne M. Hause, Rachel Cathey, Christine Feaster, Marika Mohr, Sietske de Fijter, Sarah Mitchell, Heather A. Moulton-Meissner, Isaac Benowitz, Kevin B. Spicer, Douglas A. Thoroughman
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 70:1472-1477
During December 2018-February 2019, a multistate investigation identified 101 patients with vaccination-associated adverse events among an estimated 940 persons in Kentucky, Indiana, and Ohio who had received influenza; hepatitis A; pneumococcal; or